Bruce A. Beutel
Director/Board Member at GRO Biosciences, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Russell LaMontagne | M | - |
Boston Immune Technologies & Therapeutics, Inc.
 Boston Immune Technologies & Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Immune Technologies & Therapeutics, Inc. is a company based in MA that develops a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease. The company is based in Winchester, MA. The company is also developing additional TNF superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology. The company was founded by Russell LaMontagne and he has been the CEO since incorporation. | - |
| Viswa Colluru | M | - |
Enveda Therapeutics, Inc.
 Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | - |
| Hubert Allen | M | 58 | 18 years | |
| Daniel J. Mandell | M | - |
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Kathryn Collins | F | - | 25 years | |
| Christopher J. Gregg | M | - |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Mark Bonyhadi | M | 70 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 6 years |
| Philip Boudreau | M | 51 | 27 years | |
| Gary Rieschel | M | 68 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 7 years |
| Scott Leinenweber | M | - | 27 years | |
| Mark McDade | M | 69 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 7 years |
| Pieter Dorrestein | M | - |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | - |
| P. Benjamin Stranges | M | - |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Marc J. Lajoie | M | - |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Ross Thyer | M | - |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Shaq Vayda | M | - |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | 2 years |
| Rakhshita Dhar | F | - |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 2 years |
| Rohit Sharma | M | - |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | - |
| Denise Faustman | F | - |
Boston Immune Technologies & Therapeutics, Inc.
Boston Immune Technologies & Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Immune Technologies & Therapeutics, Inc. is a company based in MA that develops a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease. The company is based in Winchester, MA. The company is also developing additional TNF superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology. The company was founded by Russell LaMontagne and he has been the CEO since incorporation. | - |
| Artavazd Arumov | M | - |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 3 years |
| Colin Walsh | M | 38 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 5 years |
| Anna Phil | M | 36 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 7 years |
| Franklin Berger | M | 74 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 5 years |
| Will McConnell | M | - |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 3 years |
| Phil DiGiacomo | M | - |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 3 years |
| Andrea Wainer | F | - | 27 years | |
| Zavain Dar | M | 35 |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | 3 years |
| Sheila Gujrathi | M | 53 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | - |
| Dror Berman | M | 45 |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | 7 years |
| Ryan Baker | M | - |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 4 years |
| Robert Headley | M | - |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | - |
| Isaac E. Ciechanover | M | 53 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | 2 years |
| John M. Capek | M | 62 | 18 years | |
| Geoff Duyk | M | 64 |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | - |
| David Healey | M | - |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Leiden | M | 68 | 6 years | |
| Murray Goldberg | M | 79 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | 4 years |
| Fred B. Parks | M | 76 | 1 years | |
| James Farrell | M | 81 | - | |
| Roxanne Austin | F | 63 | 22 years | |
| Mark Philip | M | - |
Znomics, Inc.
 Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | 2 years |
| Terrence Kearney | M | 69 | 25 years | |
| Sujata Dayal | F | 61 | 5 years | |
| Paul Clark | M | 76 | 14 years | |
| Tom R. Hodgson | M | 82 | 27 years | |
| Samuel Scott | M | 79 | 13 years | |
| Roy S. Roberts | M | 84 | - | |
| Robert Parkinson | M | 73 | 25 years | |
| Duane L. Burnham | M | 82 | 9 years | |
| Glenn Tilton | M | 75 | 16 years | |
| Laura Schumacher | F | 60 | 5 years | |
| Brian Yoor | M | 54 | 23 years | |
| David A. L. Owen | M | 85 | - | |
| Steven N. Gersten | M | - | 11 years | |
| John B. Thomas | M | - | 18 years | |
| Michael Williams | M | - | 11 years | |
| Scott Brun | M | 56 | - | |
| Eugene Sun | M | 65 | 12 years | |
| Preston T. Simons | M | - | 15 years | |
| David Stamler | M | 63 | 4 years | |
| Joe R. Sanders | M | - | 10 years | |
| Anne Borgman | M | 56 | 7 years | |
| Tejal Vakharia | M | 51 | 10 years | |
| Peter Witty | M | 56 | 10 years | |
| Bruce H. Phelps | M | - | 12 years | |
| David Pearce | M | - | 16 years | |
| Rita Jain | M | 61 | 9 years | |
| David Wheadon | M | 66 | 4 years | |
| Eric H. Sasso | M | - | - | |
| Katarzyna Mazur-Hofsaess | M | 60 | 9 years | |
| Karen Hale | F | 56 | 6 years | |
| Hing Leung Sham | M | 71 | 23 years | |
| Nancy Avila | F | 57 | 22 years | |
| Curtis Richard Jennewine | M | 56 | 3 years | |
| Todd Davis | M | 63 | 5 years | |
| Jacob John Plattner | M | 77 | 21 years | |
| Joy Amundson | F | 69 | 16 years | |
| David Milligan | M | 83 | 17 years | |
| Jose M. de Lasa | M | 82 | - | |
| Joseph M. Nemmers | M | 69 | - | |
| Richard W. Ashley | M | 79 | - | |
| H. Watkins | M | 71 | 19 years | |
| Jay B. Johnston | M | 77 | 24 years | |
| Luke Seikkula | M | 60 | 10 years | |
| Shi-Chung Ng | M | 69 | 11 years | |
| Brian Joseph Smith | M | 72 | 25 years | |
| Robert Walder | M | 71 | 6 years | |
| James Tyree | M | 71 | 12 years | |
| Karen L. Miller | F | 69 | - | |
| William C. Houghton | M | 81 | 11 years | |
| Christopher Begley | M | 71 | 18 years | |
| William Daley | M | 75 | 7 years | |
| Alan S. Rosenthal | M | - | 6 years | |
| Risa Stack | M | 55 | - | |
| Yat Sun Or | M | 72 | 14 years | |
| Walter M. Narajowski | M | 71 | 23 years | |
| Jeffrey Binder | M | 60 | 1 years | |
| Douglas Bryant | M | 66 | 24 years | |
| Jaime Contreras | F | 67 | 12 years | |
| Mike Ferry | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bruce A. Beutel
- Personal Network
